The immunosuppressant rapamycin also exhibits a weight-reducing effect, normalizing serum leptin and alleviating obesity in aged rats (Scarpace et al., 2016), perhaps by inhibiting NF-κB activation and repressing pro-inflammatory signaling (Chen et al., 2014). This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.